A gene variant called APOE4 is the biggest genetic risk factor for Alzheimer's disease. Scientists are finally figuring out ...
A particular gene variant called APOE ε4 is considered a high-risk factor for developing Alzheimer’s disease — so strong that ...
Participants raised over $727,000 during the 2026 Alzheimer's Association Walk to End Alzheimer's in Pittsburgh. Around 2,500 ...
PRI analysis shows Alzheimer’s biomarkers like Amyloid PET and plasma p-tau217 are driving earlier, precise diagnosis and staging.
After decades of research, US scientists may finally be closing in on new ways to fight Alzheimer’s. But even the most ...
Patients with early-onset Alzheimer's disease have a distinct comorbidity profile and increased healthcare use in the years before diagnosis, a study shows.
Scientists have uncovered an unexpected culprit behind sleep loss in Alzheimer’s disease: overactive immune cells in the ...
Learn how Alzheimer's disease is diagnosed through history, testing, imaging, and emerging blood biomarkers to support early ...
Alzheimer's disease is best known for its effects on memory and cognition, but the disease also involves changes in how brain ...
Shanghai Fosun Pharmaceuticals secured regional rights to AR1001 via a $60M option fee. Find out why SFOSF stock is a hold.
A new conceptual framework called the Gut-Brain Homeostatic Continuum reframes Alzheimer's disease as a progressive erosion ...
Boosting a protein restored brain rhythms and improved memory in mice with Alzheimer’s-like disease, pointing to a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results